Muhammad Ilyas Tariq
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Muhammad Ilyas Tariq has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Nargis Sultana
Department of Chemistry , University of Sargodha , Sargodha 40100 , Pakistan
2 shared publicationsAima Iram
Department of Biological Sciences University of Sargodha Sargodha-40100 Pakistan
1 shared publicationGhulam Khadija
Department of Chemistry University of Sargodha Sargodha-40100 Pakistan
1 shared publicationMasood Parvez
Department of Chemistry , University of Calgary , 2500 University Drive, N.W. Calgary , Alberta T2N 1N4 , Canada
1 shared publicationMehwish Aslam
Department of Chemistry University of Sargodha Sargodha-40100 Pakistan
1 shared publicationMuhammad Fayyaz-Ur-Rehman
Department of Chemistry University of Sargodha Sargodha-40100 Pakistan
1 shared publication
Latest Publications
- 30 May 2019
- Published by Walter de Gruyter GmbH in Zeitschrift für Kristallographie - Crystalline Materials
- Vol. 234 (9) , 605-611
Synthesis, molecular packing and anti-cholinesterase activity of some new C-2 N-substituted anthranilamide derivatives
Synthesis of C-2 N-substituted anthranilamide derivatives was carried out in a straight forward manner, utilizing 2-aminobenzamide and benzyl chloride as starting materials. Their crystal structures have been established by single crystal X-ray crystallographic method. In the molecules of 2-benzylamino-benzamide (3a), intramolecular hydrogen bonding b/w O atom and proton of –NH and classical intermolecular hydrogen bonding of the type N–H · · · O forming eight membered rings in R4 2(8) pattern. In both molecules of 2-(dibenzylamino)benzamide (3b), unlike the molecule in 3a, each H atoms is pointed towards N atom causing intramolecular hydrogen bonding interactions, resulting in S(6) motifs. However, it is interesting to note that both molecules in 3b are lying about inversion centres and form dimers in R4 2(8) motifs; the two dimers are linked via non-classical intermolecular hydrogen bonds C–H · · · O resulting in clusters of four molecules in the structure. In vitro assay results revealed that molecule 3b with IC50 values of 3.8 ± 0.08 μM (AChE) and 17.6 ± 1.10 μM (BChE) possessed better cholinesterase (AChE and BChE) inhibition potential as compared to standard drug galantamine. Preliminary in silico studies showed that more biological active derivatives were also having good pharmacokinetic profile with no AMES toxicity and carcinogenicity.
- 30 May 2019
- Published by Walter de Gruyter GmbH in Zeitschrift für Kristallographie - Crystalline Materials
- Vol. 234 (9) , 605-611
Synthesis, molecular packing and anti-cholinesterase activity of some new C-2 N-substituted anthranilamide derivatives
Synthesis of C-2 N-substituted anthranilamide derivatives was carried out in a straight forward manner, utilizing 2-aminobenzamide and benzyl chloride as starting materials. Their crystal structures have been established by single crystal X-ray crystallographic method. In the molecules of 2-benzylamino-benzamide (3a), intramolecular hydrogen bonding b/w O atom and proton of –NH and classical intermolecular hydrogen bonding of the type N–H · · · O forming eight membered rings in R4 2(8) pattern. In both molecules of 2-(dibenzylamino)benzamide (3b), unlike the molecule in 3a, each H atoms is pointed towards N atom causing intramolecular hydrogen bonding interactions, resulting in S(6) motifs. However, it is interesting to note that both molecules in 3b are lying about inversion centres and form dimers in R4 2(8) motifs; the two dimers are linked via non-classical intermolecular hydrogen bonds C–H · · · O resulting in clusters of four molecules in the structure. In vitro assay results revealed that molecule 3b with IC50 values of 3.8 ± 0.08 μM (AChE) and 17.6 ± 1.10 μM (BChE) possessed better cholinesterase (AChE and BChE) inhibition potential as compared to standard drug galantamine. Preliminary in silico studies showed that more biological active derivatives were also having good pharmacokinetic profile with no AMES toxicity and carcinogenicity.
- Open Access
- 9 May 2018
- Published by African Journals Online (AJOL) in Tropical Journal of Pharmaceutical Research
- Vol. 17 (3) , 451-459
Tris-diamine-derived transition metal complexes of flurbiprofen as cholinesterase inhibitors
Tris-diamine-derived transition metal complexes of flurbiprofen as cholinesterase inhibitors
- 9 May 2018
- Published by African Journals Online (AJOL) in Tropical Journal of Pharmaceutical Research
- Vol. 17 (3) , 451-459
Open AccessTris-diamine-derived transition metal complexes of flurbiprofen as cholinesterase inhibitors
Tris-diamine-derived transition metal complexes of flurbiprofen as cholinesterase inhibitors
- Open Access
- 11 May 2009
- Published by Bentham Science Publishers Ltd. in The Open Enzyme Inhibition Journal
- Vol. 2 (1) , 8-11
Inhibition Studies of Cellulolytic Activities Isolated from Planococcus Citri
Inhibition Studies of Cellulolytic Activities Isolated from Planococcus Citri
- 11 May 2009
- Published by Bentham Science Publishers Ltd. in The Open Enzyme Inhibition Journal
- Vol. 2 (1) , 8-11
Open AccessInhibition Studies of Cellulolytic Activities Isolated from Planococcus Citri
Inhibition Studies of Cellulolytic Activities Isolated from Planococcus Citri